Pharmaceutical Business review

China Nuokang Q2 net revenue falls

The company has posted a net income of RMB14.14m for the second quarter of 2011, compared to RMB19.39m for the same period in 2010.

China Nuokang has generated gross profit of RMB70.87m, against RMB73.17m for the same period prior year.

For the six months ended 30 June 2011, the company reported net revenue of RMB144.01m, compared to RMB152.14m for the same period in 2010.

China Nuokang has reported net income of RMB25.04m for the six months ended 30 June 2011, against RMB36.46m for the same period in 2010.

For the six months ended 30 June 2011, the company’s gross profit was RMB127.12m, compared to RMB135.56m for the same period prior year.

China Nuokang chairman and CEO Baizhong Xue said the first quarter was affected by the sales team reorganization process but this quarter shows that they have quickly resumed normal operations.

"Moving forward, we expect our reorganization to strengthen the reach and effectiveness of our distribution network," Xue said.